Luciani L, Pedrelli M, Parini P. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes. Atherosclerosis. 2024;394:117545.

Article  PubMed  CAS  Google Scholar 

Martagon AJ, Zubiran R, Gonzalez-Arellanes R, Praget-Bracamontes S, Rivera-Alcantara JA, Aguilar-Salinas CA. HDL abnormalities in type 2 diabetes: Clinical implications. Atherosclerosis. 2023;394:117213.

Article  PubMed  CAS  Google Scholar 

Pencina KM, Pencina MJ, Dufresne L, Holmes M, Thanassoulis G, Sniderman AD. An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study. Lancet Healthy Longev. 2022;3(5):e339–46.

Article  PubMed  Google Scholar 

Marazziti D, Placidi GF, Cassano GB, Akiskal HS. Lack of specificity of reduced platelet imipramine binding in different psychiatric conditions. Psychiatry Res. 1989;30(1):21–9.

Article  PubMed  CAS  Google Scholar 

Swerdlow DI, Sattar N. Blood Lipids and Type 2 Diabetes Risk: Can Genetics Help Untangle the Web? Diabetes. 2015;64(7):2344–5.

Article  PubMed  CAS  Google Scholar 

Gonzalez-Lleo AM, Sanchez-Hernandez RM, Boronat M, Wagner AM. Diabetes and familial hypercholesterolemia: interplay between lipid and glucose metabolism. Nutrients. 2022;14(7):1–23.

Article  Google Scholar 

White J, Swerdlow DI, Preiss D, Fairhurst-Hunter Z, Keating BJ, Asselbergs FW, et al. Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes. JAMA Cardiol. 2016;1(6):692–9.

Article  PubMed  PubMed Central  Google Scholar 

Qi Q, Liang L, Doria A, Hu FB, Qi L. Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts. Diabetes. 2012;61(3):745–52.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dixit M, Bhattacharya S, Mittal B. Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study. BMC Endocr Disord. 2005;5:7.

Article  PubMed  PubMed Central  Google Scholar 

Liu DJ, Peloso GM, Yu H, Butterworth AS, Wang X, Mahajan A, et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat Genet. 2017;49(12):1758–66.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wong THT, Mo JMY, Zhou M, Zhao JV, Schooling CM, He B, et al. A two-sample Mendelian randomization study explores metabolic profiling of different glycemic traits. Commun Biol. 2024;7(1):293.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brouwers MC, van Greevenbroek MM, Stehouwer CD, de Graaf J, Stalenhoef AF. The genetics of familial combined hyperlipidaemia. Nat Rev Endocrinol. 2012;8(6):352–62.

Article  PubMed  CAS  Google Scholar 

Zubiran R, Vargas-Vazquez A, Olvera FDR, Cruz-Bautista I, Martagon-Rosado A, Sampson M, et al. Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia. Atherosclerosis. 2023;386: 117364.

Article  PubMed  CAS  Google Scholar 

Skoumas I, Masoura C, Aznaouridis K, Metaxa V, Tsokanis A, Papadimitriou L, et al. Impact of cardiometabolic risk factors on major cardiovascular events in patients with familial combined hyperlipidemia. Circ J. 2013;77(1):163–8.

Article  PubMed  CAS  Google Scholar 

Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, Hunt SC. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2003;108(5):519–23.

Article  PubMed  Google Scholar 

Skoumas J, Papadimitriou L, Pitsavos C, Masoura C, Giotsas N, Chrysohoou C, et al. Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia. Metabolism. 2007;56(1):135–41.

Article  PubMed  CAS  Google Scholar 

Naukkarinen J, Ehnholm C, Peltonen L. Genetics of familial combined hyperlipidemia. Curr Opin Lipidol. 2006;17(3):285–90.

Article  PubMed  CAS  Google Scholar 

Ylitalo K, Syvanne M, Salonen R, Nuotio I, Taskinen MR, Salonen JT. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia. Atherosclerosis. 2002;162(1):171–8.

Article  PubMed  CAS  Google Scholar 

Packard CJ, Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol. 1997;17(12):3542–56.

Article  PubMed  CAS  Google Scholar 

Gaddi A, Cicero AF, Odoo FO, Poli AA, Paoletti R, Atherosclerosis, Metabolic Diseases Study G. Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. Vasc Health Risk Manag. 2007;3(6):877–86.

PubMed  PubMed Central  CAS  Google Scholar 

Keulen ET, Voors-Pette C, de Bruin TW. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass. Am J Hypertens. 2001;14(4 Pt 1):357–63.

Article  PubMed  CAS  Google Scholar 

Bredie SJ, Kiemeney LA, de Haan AF, Demacker PN, Stalenhoef AF. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet. 1996;58(4):812–22.

PubMed  PubMed Central  CAS  Google Scholar 

Vakkilainen J, Jauhiainen M, Ylitalo K, Nuotio IO, Viikari JS, Ehnholm C, Taskinen MR. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. J Lipid Res. 2002;43(4):598–603.

Article  PubMed  CAS  Google Scholar 

Guerin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol. 2001;21(2):282–8.

Article  PubMed  CAS  Google Scholar 

Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260(13):1917–21.

Article  PubMed  CAS  Google Scholar 

ter Avest E, Sniderman AD, Bredie SJ, Wiegman A, Stalenhoef AF, de Graaf J. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia. Clin Sci (Lond). 2007;112(2):131–9.

Article  PubMed  Google Scholar 

Brouwers M, de Graaf J, Simons N, Meex S, Ten Doeschate S, van Heertum S, et al. Incidence of type 2 diabetes in familial combined hyperlipidemia. BMJ Open Diabetes Res Care. 2020;8(1):1–8.

Article  Google Scholar 

Skoumas I, Ioakeimidis N, Vlachopoulos C, Chrysohoou C, Michalakeas C, Georgakopoulos C, et al. Statin therapy and risk of diabetes mellitus in aging patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia: a 10-year follow-up. Angiology. 2018;69(3):242–8.

Article  PubMed  Google Scholar 

Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM. Genetics of familial combined hyperlipidemia (FCHL) disorder: an update. Biochem Genet. 2022;60(2):453–81.

Article  PubMed  CAS  Google Scholar 

Bruikman CS, Hovingh GK, Kastelein JJP. Molecular basis of familial hypercholesterolemia. Curr Opin Cardiol. 2017;32(3):262–6.

Article  PubMed  Google Scholar 

Mehta R, Zubiran R, Martagon AJ, Vazquez-Cardenas A, Segura-Kato Y, Tusie-Luna MT, Aguilar-Salinas CA. The panorama of familial hypercholesterolemia in Latin America: a systematic review. J Lipid Res. 2016;57(12):2115–29.

Article